IP Library › Granted Patent US 11,781,126
Granted Patent B2
US 11,781,126 · App. 17/985,821 · Granted Oct 10, 2023

Using proteases to control star activity of restriction enzymes

Inventors: Zhenyu Zhu (Lynnfield, MA); Dapeng Sun (Lexington, MA); Aine Quimby (Newburyport, MA); Michaela Shottes (Methuen, MA)
Assignee: ABclonal Science, Inc.
C12N9/22C12Q1/37
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,781,126
App. No.
17/985,821
Granted
Oct 10, 2023
Kind
B2
Abstract

Proteases are enzymes which hydrolyze protein enzymes, eliminating their activity. The present invention exploits the hydrolyzing activity of proteases including proteinase K, endoproteinase LysC and/or trypsin to control the activity of restriction enzymes and/or eliminate or reduce production of unwanted DNA or RNA fragments (known as star activity).

Claims (8)

1. A process of inhibiting or preventing star activity by a restriction endonuclease comprising:

digesting an oligomer using a reaction mixture comprising a restriction endonuclease, buffer and oligomer;

including in the reaction mixture proteinase K, endoproteinase LysC and/or trypsin buffer and oligomer, in order to inhibit or prevent star activity by the restriction endonuclease; and

terminating the digestion by adding a stopping solution including a loading dye.

2. The process of claim 1 wherein the restriction endonuclease is EcoRI, NcoI or BamHI.

3. The process of claim 1 wherein the substrate is lambda DNA.

4. The process of claim 1 wherein the buffer is selected from the group consisting of: 20 mM Tris-HCl, pH 7.4, 40 mM KoAc, 10 mM MgCl 2 , 0.1 mM CaCl 2 ; 20 mM Tris-HCl, pH 7.5, 40 mM NaCl, 10 mM MgCl 2 , 0.1 mM CaCl 2 ; and, 20 mM Tris-HCl, pH 8.0.

5. The process of claim 1 wherein the stopping solution includes 2.5% Ficoll®-400, 11 mM EDTA (pH 8.0), 3.3 mM Tris-HCl, 0.017% SDS, 0.015% bromophenol blue.

Continuity (4)
Continuation 17171017 · Feb 9, 2021
Continuation 17062471 · Oct 2, 2020
Provisional Application 62916927 · Oct 18, 2019
Related Publication 20230111383A1 · Apr 13, 2023